Milica Kontic Jovanovic

1. MOHORČIČ, Katja, KONTIC JOVANOVIC, Milica. Late-onset immune-related toxicity of CPI in the treatment of NSCLC : 60th Oncology Congress, November 29, 2023 - December 2, 2023, Belgrade, Serbia. [COBISS.SI-ID 177557507]

2. MARKOVIC, F., KONTIC JOVANOVIC, Milica, JANŽIČ, Urška. Efficacy of first-line pembrolizumab in elderly patients with advanced non-small cell lung cancer with high PD-L1 expression. V: European Lung Cancer Congress 2024 : 20-23 March 2024 : abstract book. London: BMJ, 2024. [abstract no.] 94p, str. 46-47. ESMO open, Vol. 9, suppl. 3, Mar. 2024. ISSN 2059-7029. DOI: 10.1016/j.esmoop.2024.102673. [COBISS.SI-ID 235720195]

3. MARKOVIĆ, Filip, HOCHMAIR, Maximilian J, MÜSER, Nino, FABIKAN, Hannah, RODRIGUEZ, Vania Mikaela, JANŽIČ, Urška, STJEPANOVIĆ, Mihailo, KONTIC JOVANOVIC, Milica. The efficacy of first-line pembrolizumab monotherapy in patients with metastatic NSCLC aged ≥70 years with high PD-L1 (TPS ≥50%) expression: a multicenter real-world study. Cancers. 2025, vol. 17, issue 13, [article no.] 2190, 13 str., ilustr. ISSN 2072-6694. https://www.mdpi.com/2072-6694/17/13/2190, DiRROS - Digitalni repozitorij raziskovalnih organizacij Slovenije, DOI: 10.3390/cancers17132190. [COBISS.SI-ID 240793091]